2021
DOI: 10.21873/anticanres.15262
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic Value of CD45Ro+ T-Cell Expression in Patients With Oral Squamous Cell Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…[ 21 , 30 , 31 , 32 ]. CD45RO+ TILs in oral squamous cell carcinoma have been investigated multiple times and were unanimously described as a positive prognostic factor [ 17 , 18 , 19 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 21 , 30 , 31 , 32 ]. CD45RO+ TILs in oral squamous cell carcinoma have been investigated multiple times and were unanimously described as a positive prognostic factor [ 17 , 18 , 19 ].…”
Section: Discussionmentioning
confidence: 99%
“…A meta-analysis by Hu et al concluded that CD45RO+ T cells are a “valuable biomarker for prognostic prediction of human solid malignancies”. Their positive prognostic value has been demonstrated for colorectal cancer (CRC), hepatocellular cancer (HCC), gastric cancer (GC), esophageal cancer (EC), and oral squamous cell carcinoma (OSCC) [ 12 , 17 , 18 , 19 ]. In CRC, CD45RO+ T cells strongly correlated with tumor downstaging and long-term outcome after neoadjuvant hypofractionated radiotherapy, indicating a possible role for memory T cells in patient stratification and detection of the most suitable candidates for radiotherapy.…”
Section: Introductionmentioning
confidence: 99%
“…Naturally, HLA markers are essential for antigen presentation and display a pivotal role in antitumor immunity by enhancing immunosurveillance and preventing immune escape. Additionally, high HLA class I expression in OSCC shows a significantly positive connection with a better prognosis (Koike et al, 2020;Anderson et al, 2021). Besides, it is worth emphasizing that various immune cells in the TME participate in anti-tumor immune responses as main components.…”
Section: Discussionmentioning
confidence: 98%
“…HLA class I expression appears to be lost or downregulated on the tumor cell surface, which could represent a mechanism by which neoplastic cells escape killing by CTLs, allowing tumor dissemination and metastasis (Pistillo et al, 2000). HLA class I antigen downregulation has been used as a prognostic biomarker in esophageal cancer (Hosch et al, 1997), melanoma (Kageshita et al, 1999), lung cancer (Kikuchi et al, 2007), ovarian cancer (Vitale et al, 2005), renal cell carcinoma (Kitamura et al, 2007), bladder cancer (Homma et al, 2009), and oral squamous cell carcinoma (Koike et al, 2020) and has improved the survival of patients. In our study, the expression levels of class I HLA molecules, which are responsible for antigen presentation to tumor-killing T-cells, and the expression levels of class II HLA molecules, which are responsible for antigen presentation to helper T-cells, were decreased in some patients.…”
Section: Discussionmentioning
confidence: 99%